OMOR Or Not To OMOR: Proposals Will Push US OTC Monograph Fees Past Requested Level

Payments FDA receives could expand from facility fees between $13,548 and $20,322 collected from around 1,700 firms for the current fiscal year to include payments of $500,000 or $100,000 from firms for proposed monograph changes.

OTC monograph drug program user fees the US Food and Drug Administration requested for fiscal year 2022 are up slightly from the agency’s current budget, but the total amount it collects in the 12 months starting October could be much larger.

That’s because the payments the FDA receives under the program could expand from the facility fees from around 1,700 firms...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from HBW Insight

Moberg Nail Fungus Line Takes Lead In Norway As Firm Plots EU Expansion

 
• By 

Terclara - Moberg’s proprietary topical formulation of terbinafine for fungal nail - has established itself as the market leader in Norway just months after its OTC launch. The firm is now plotting its expansion to additional EU markets.

PAGB: UK Gov Must Invest In Self-Care To Realize ‘Untapped Potential’

 
• By 

Reacting to chancellor Rachel Reeves' 2025 public spending review, PAGB welcomed increased funding for healthcare and life sciences while stressing the need to promote self-care practices.

Summer Beauty: Scalp, Hair Growth Ranges, Lip Balms Under Beauty/Food Deals

 

Arbonne International’s Hair Care Collection Scalp Elixir demonstrated improvement in scalp buildup in 96% of participants in a small study. Separately, It’s a 10 Haircare has extended with a new range, F.A.S.T. Haircare, clinically proven to grow hair up to 99% faster; Beauty Launch Roundup